Endocrine Disruptors and Fertility: What Should Endocrinologists Be Advising? Abstract Endocrine-disrupting chemicals (EDCs) have emerged as a notable concern in reproductive health, with increasing evidence linking exposure to reduced fertility in both men and women. These compounds, which include a broad spectrum of
Internal Medicine
Autoimmunity and COVID Vaccines: Risk of Flares or Protective Benefits? A Comprehensive Analysis for Academic and Industry Experts
Autoimmunity and COVID Vaccines: Risk of Flares or Protective Benefits? A Comprehensive Analysis for Academic and Industry Experts Abstract The link between getting a COVID-19 vaccine and having an autoimmune disease is an intricate blend of immunology, public health, and clinical practice. This analytical review
Giant Cell Arteritis and the Rapid Rise of Tocilizumab: Are Steroids Obsolete?
Giant Cell Arteritis and the Rapid Rise of Tocilizumab: Are Steroids Obsolete? Abstract Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis in adults over 50 years of age and represents a major cause of morbidity, particularly when diagnosis and treatment are delayed. Traditionally, management
The “Pre-Pre-Diabetes” Zone: Are We Overdiagnosing Glycemic Risk?
The “Pre-Pre-Diabetes” Zone: Are We Overdiagnosing Glycemic Risk? Check back later for a possible video summary. Abstract Recent advancements in the understanding of glycemic dysregulation have led to more sensitive criteria for diagnosing prediabetes. As a result, growing concern has emerged regarding